Monthly Archives: December 2019

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of IRBT, REZI and CGC

NEW YORK, NY / ACCESSWIRE / December 19, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

iRobot Corporation (NASDAQ:IRBT)
Class Period: November 21, 2016 to October 22, 2019
Lead Plaintiff Deadline: December 23, 2019

The filed complaint alleges that defendants misrepresented the reason for iRobot's acquisitions of Tokyo-based Sales on Demand Corporation and privately-held Robopolis SAS, which was to control the Company's largest distributors so that defendants could inflate sales and revenue figures by stuffing the channel. Defendants further misled investors by repeatedly telling them throughout the Class Period that the Company was seeing continued double-digit revenue growth, and by attributing the growth to increased demand for the Roomba vacuums, when in reality defendants were engaging in channel-stuffing to artificially boost sales. Defendants also misstated that the Company's channel inventory levels had not changed and would not change dramatically from quarter to quarter or year over year, when in fact iRobot was deliberately stuffing the channel in order to claim false revenue growth.

Learn about your recoverable losses in IRBT: http://www.kleinstocklaw.com/pslra-1/irobot-corporation-loss-submission-form?id=4958&from=1

Resideo Technologies, Inc. (NYSE:REZI)
Class Period: October 29, 2018 to October 22, 2019
Lead Plaintiff Deadline: January 7, 2020

According to the complaint, Resideo Technologies, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (a) the negative operational effects of the Company's spin-off from Honeywell International Inc. were more substantial and persistent than disclosed and had negatively affected Resideo's product sales, supply chain, and gross margins, putting the Company's FY19 financial forecasts at risk; and (b) as a result of the foregoing, the Company's financial guidance lacked a reasonable basis and the Company was not on track to make its FY19 guidance as claimed.

Learn about your recoverable losses in REZI: http://www.kleinstocklaw.com/pslra-1/resideo-technologies-inc-loss-submission-form?id=4958&from=1

Canopy Growth Corporation (NYSE:CGC)
Class Period: June 21, 2019 to November 13, 2019
Lead Plaintiff Deadline: January 20, 2020

The complaint alleges Canopy Growth Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing weak demand for its softgel and oil products; (2) as a result, the Company would be forced to take a CA$32.7 million restructuring charge due to poor sales, excessive returns, and excess inventory; and (3) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Learn about your recoverable losses in CGC: http://www.kleinstocklaw.com/pslra-1/canopy-growth-corporation-loss-submission-form?id=4958&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 570784

Flexpoint Enters into Half-Million-Dollar Licensing Agreement with Neptune Control, LLC, Maker of state-of-the-art Moisture Detection System

New Trident Moisture Detector® will utilize Flexpoint's Bend Sensor® as a part of their ground-breaking technology in lawn and green space care and conservation

DRAPER, UT / ACCESSWIRE / December 19, 2019 / Flexpoint Sensor Systems, Inc. (OTC PINK:FLXT) has entered into a five-year, half-million-dollar Licensing Agreement with Neptune Controls, LLC, an environmentally conscience, Utah-based company dedicated to the conservation of water. The agreement included the first payment of $100,000 with the execution of the agreement and the balance to be paid in four additional installments over the course of next four years, licenses the use of Flexpoint's Bend Sensor technology to detect the presence of moisture in soil, effectively shutting down a sprinkler system when a precise and optimum level of moisture is reached.

According to the EPA's WaterSense, landscape irrigation accounts for nearly one-third of all residential water use, totaling more than 7 billion gallons per day. There are somewhere around 40 million acres of lawn in the lower 48, according to a 2005 NASA estimate derived from satellite imaging. "Turf grasses, occupying 1.9% of the surface of the continental United States, would be the single largest irrigated crop in the country.

"Current sprinkler systems continue to water beyond what is needed to keep a green space healthy," explained Josh Quai, Director of Operations at Neptune Control. "Watering an average-sized lawn accounts for seventy percent of a normal water bill, and half of that is wasted due to the inefficiencies of current systems. Our Trident System uses solar energy to power the sensor, effectively measuring the smallest amount of moisture in the soil allowing consumers to use water in a more conservative manner."

At the heart of Neptune Control's Trident System is the Flexpoint Bend Sensor. Flexpoint has worked hand-in-hand with Neptune Control during testing and trials to develop a precise watering system that will potentially impact millions of sprinkler systems, saving billions of dollars and the world's most precious resource-water.

"The bend sensor in this configuration is very effective measuring water content without being influenced or compromised by the conductive content or minerals in the soil," said Dave Beck, Director of Flexpoint Engineering.

Each solar-powered sensor is protected by a durable sheath and designed to slip easily into the soil near a sprinkler head in each watering zone, detecting with remarkable accuracy the moisture level in the soil. Working in conjunction with a proprietary software program, the Neptune System shuts down when the soil reaches the pre-determined parameter set by the owner. A smartphone app is included in the system, keeping the owner up to date on the health and wetness of their green space.

"With the potential to impact the environment enormously," said Clark Mower, CEO of Flexpoint. "Flexpoint is once again poised to utilize the power of the Bend Sensor® as we partner with Neptune Control to help save money and water."

The leading supplier of thin film sensing technology, Flexpoint is dedicated to delivering the most innovative and cost-effective solutions to companies around the globe.

About Flexpoint Sensor Systems, Inc.

Flexpoint Sensor Systems, Inc. (FLXT) is an innovative technology firm specializing in developing products that feature the Company's patented Bend Sensor® and related technology. The Bend Sensor® is a groundbreaking sensing solution that is revolutionizing applications in the automotive, safety, medical and industrial industries. The Bend Sensor® single-layer, thin film construction cuts costs and mechanical bulk while introducing a range of functions and stylistic design possibilities that have never before been available in sensing technology. Flexpoint's technology and expertise have been recognized by the world's elite business and academic innovators for over 17 years. The company is setting a new standard for sensing solutions in the "smart" age of technology.

Forward-Looking Statements

This press release contains certain forward-looking statements. Investors are cautioned that certain statements in this release are "forward-looking statements" and involve both known and unknown risks, uncertainties and other factors. Such uncertainties include, among others, certain risks associated with the operation of the company described above. The Company's actual results could differ materially from expected results.

Contact Information:

Flexpoint Sensor Systems
Clark Mower, President
801-568-5111

Brokers and Analysts
Chesapeake Group
410-825-3930

SOURCE: Flexpoint Sensor Systems, Inc.

ReleaseID: 570782

SHAREHOLDER ALERT: UNIT INFY BZUN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / December 19, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Uniti Group Inc. (NASDAQGS:UNIT)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/uniti-group-inc-loss-submission-form?prid=4963&wire=1
Lead Plaintiff Deadline: December 30, 2019
Class Period: April 20, 2015 to February 15, 2019

Allegations against UNIT include that: (i) Uniti's financial results were not sustainable because its customer Windstream had defaulted on its unsecured notes; and (ii) as a result of the foregoing, Defendants' statements about Uniti's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

Infosys Limited (NYSE:INFY)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/infosys-limited-loss-submission-form?prid=4963&wire=1
Lead Plaintiff Deadline: December 23, 2019
Class Period: July 7, 2018 to October 20, 2019

Allegations against INFY include that: (1) the Company improperly recognized revenues to inflate short-term profits; (2) Chief Executive Officer Salil Parekh bypassed reviews and approvals for large deals to avoid accounting scrutiny; (3) management pressured the Company's finance team to hide information from auditors and the Company's Board of Directors; and (4) as a result of the aforementioned misconduct, Defendants' statements about Infosys's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

Baozun Inc. (NASDAQ:BZUN)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/baozun-inc-loss-submission-form?prid=4963&wire=1
Lead Plaintiff Deadline: February 10, 2020
Class Period: Baozun American Depository Receipts between March 6, 2019 and November 20, 2019

Allegations against BZUN include that: (a) Baozun was heavily reliant upon a single brand partner, Huawei, for the exponential service fee growth it had been reporting historically, which was in turn fueling its historical revenue growth; (b) compared to other brands Baozun had as brand partners, the Huawei work had historically included a lot of additional add-on service fees, increasing the revenue reported from Huawei vis-a-via its other brand partners; (c) Huawei, like other large brands, was actively preparing to bring its online merchandising in-house, meaning Baozun knew that it was losing a significant brand partner; and (d) as a result of the foregoing, the Company was not on track to achieve the financial results and performance Defendants claimed the Company was on track to achieve during the class period.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 570789

SHAREHOLDER ALERT: AZZ PLT PRU: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / December 19, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

Azz, Inc. (NYSE:AZZ)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/azz-inc-loss-submission-form?prid=4962&wire=1
Lead Plaintiff Deadline: January 3, 2020
Class Period: July 3, 2018 to October 8, 2019

Allegations against AZZ include that: (1) the Company's internal controls over financial reporting were not effective; (2) the Company improperly implemented ASC 606 which resulted in improper revenue reconciliations; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Plantronics, Inc. (NYSE:PLT)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/plantronics-inc-loss-submission-form?prid=4962&wire=1
Lead Plaintiff Deadline: January 13, 2020
Class Period: July 2, 2018 to November 5, 2019

Allegations against PLT include that: (1) the Company had engaged in channel stuffing to artificially boost sales; (2) the Company's internal control over inventory levels was not effective; (3) the Company had not adequately monitored inventory levels ahead of multiple product launches, where the new models would displace demand for aging products; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Prudential Financial, Inc. (NYSE:PRU)

If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/prudential-financial-inc-loss-submission-form?prid=4962&wire=1
Lead Plaintiff Deadline: January 27, 2020
Class Period: February 15, 2019 to August 2, 2019

Allegations against PRU include that: (a) the Company's reserve assumptions failed to account for adversely developing mortality experience in the Individual Life business segment; (b) the Company was not over-reserved, but instead, its reported reserves, particularly for the Individual Life business segment, were insufficient to satisfy its future policy benefits liabilities; and (c) the Company had materially understated its liabilities and overstated net income as a result of flawed assumptions in calculating mortality experience.

To learn more contact Vincent Wong, Esq. either via email vw@wongesq.com or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

SOURCE: The Law Offices of Vincent Wong

ReleaseID: 570788

Frelii Announces International License and Profit Sharing Agreement

Frelii Announces International License and Profit Sharing Agreement

Company expands its genome discovery AI footprint into Canada

LEHI, UT / ACCESSWIRE / December 19, 2019 / Frelii, Inc. (OTC PINK:FRLI) ("Frelii" or the "Company"), a biotechnology company working to commercialize its patent-pending DNA gene sequencing artificial intelligence technology, announced today it has signed a License and Profit Sharing Agreement ("Agreement) with Genecor AI Inc. and Genecor Labs Inc. ("Customers").

"We are pleased to realize a significant revenue inflection point today with licensing of our Navii AI technology. In partnering with Genecor, Frelii effectively gains access to foreign markets ahead of schedule and enables the Company to further its objective of improving patient outcomes while building long-term shareholder value".

Under the terms of the Agreement, Genecor AI Inc., a Canadian Company, has acquired the International rights (excluding the USA), to Frelii's patent pending AI, Navii for $750,000 payable in installments over 3 months. Through its network of medical professionals, Genecor AI will market Frelii's DNA technology in Canadian market, with plans to expand to other jurisdictions. Along with its sister company, Genecor Labs Inc., Genecor AI plans to provide a fully integrated DNA analysis experience.

Additionally, the companies have signed a Collaboration Agreement whereby Frelii participates in 25% of the earnings of Genecor AI Inc. and Genecor Labs Inc. in Canada, and share equally from any earnings from joint ventures outside of Canada and the USA.

About Genecor AI Inc.

With headquarters in Toronto, ON, and offices in Mississauga, ON, Genecor AI Inc., a subsidiary of Helix Investments Partners Inc., provides research institutions, allied health care partners, and health and wellness companies powerful tools to push the boundaries of science and to interpret and synthesize data. The company's push for continuous innovation addresses local needs in a burgeoning personalized health & wellness industry requiring smart solutions.

About Genecor Labs Inc.

With headquarters in Toronto, ON, and offices in Mississauga, ON, Genecor Labs Inc., a subsidiary of Helix Investments Partners Inc., aims to make whole-genome testing affordable and provide information to people that will help them maximize their quality of life through meaningful and accurate results related to health, nutrition, and fitness. Together with Genecor AI's interpretive engine, Genecor Labs aims to launch the most complete and accurate DNA testing on the market starting the Spring of 2020.

For more information please visit www.genecor.ai.

About Frelii Inc.

Frelii Inc. is a biotechnology company utilizing human DNA gene sequencing and artificial intelligence (AI) to assess more than 3.2 billion markers on the human genome. The resulting data provides valuable insight into an individual's DNA which are aligned and leveraged against its AI as a means of creating a robust data platform for use by a variety of sectors, including Health & Wellness, Healthcare, Medical Cannabis and Pharmaceutical.

For more information, please visit www.frelii.com or follow us online at:

Frelii Facebook Page https://www.facebook.com/livefrelii/
Frelii Twitter Feed @livefrelii
Frelii Instagram Page @livefrelii
Frelii LinkedIn Page linkedin.com/company/frelii/

For questions or inquiries, please contact Seth Jones: sethjones@frelii.com

Safe Harbor Statement:

This release contains certain "forward-looking statements" relating to the business of the Company. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements regarding: the continued growth of the e-commerce segment and the ability of the Company to continue its expansion into that segment; the ability of the Company to attract customers and partners and generate revenues; the ability of the Company to successfully execute its business plan; the business strategy, plans, and objectives of the Company; and any other statements of non-historical information. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions and involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this news release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume any duty to update these forward-looking statements.

SOURCE: Frelii Inc.

ReleaseID: 570781

Organto Announces 2019 Annual General Meeting Results

VANCOUVER, BC / ACCESSWIRE / December 19, 2019 / Organto Foods Inc. (TSXV:OGO)(OTC:OGOFF) ("Organto" or "the Company"), today announced the results from its 2019 Annual General Meeting that was held on December 18, 2019 in Vancouver, British Columbia.

At the meeting 29,611,843 shares representing approximately 17% of eligible outstanding shares were voted with all matters before the meeting receiving in excess of 99% support.

Shareholders elected six directors: Steve Bromley, Peter Gianulis, Robert Giustra, Alejandro Maldonado, Javier Reyes and Claudio Schreier. Mr.'s Giustra, Maldonado, Reyes and Schreier were elected as independent directors, representing 66.67% of the directors elected to the board.

The shareholders also approved the appointment of Dale Matheson Carr-Hilton Labonte LLP, Chartered Professional Accountants, as Organto's independent auditor for the ensuing year and resolved that the Company's Share Option Plan be ratified and approved for continuation until the Company's next Annual General Meeting.

The Company also announced that it has completed the shares for debt transactions originally announced on September 26, 2019 and November 15, 2019 and has issued 2,027,579 common shares of the Company at prices of ranging from $0.055 to $0.065 per share to settle debt in the amount of $123,548. $12,500 of this debt is for management fees to an employee incurred during the period June 2018 to May 2019. The balance of $111,048 is for products and services provided to the Company in 2018. The shares issued under these shares for debt settlements have hold periods ending between April 11, 2020 and December 11, 2020.

ON BEHALF OF THE BOARD,

Steve Bromley
Chair and Interim Chief Executive Officer

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

For more information contact:

Investor Relations
1-888-818-1364
info@organto.com

ABOUT ORGANTO

Organto's business model is rooted in its commitment to sustainable business practices focused on environmental responsibility and a commitment to the communities where it operates, its people and its shareholders. The Organto Foods Group is an integrated provider of year-round value-added branded organic vegetables and seasonal organic and non-GMO fruit and vegetable products using an asset-light business model to serve a growing socially responsible and health conscious consumer around the globe.

SOURCE: Organto Foods Inc.

ReleaseID: 570780

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed an Amended Complaint to Recover Losses Suffered by Bloom Energy Corporation Investors

NEW YORK, NY / ACCESSWIRE / December 19, 2019 / Levi & Korsinsky, LLP filed an amended complaint against Bloom Energy Corporation ("Bloom Energy") (NYSE:BE) and its officers, directors, and underwriters on November 4, 2019. Levi & Korsinsky filed the amended complaint in its ongoing class action lawsuit pending in the United States District Court for the Northern District of California.

On September 3, 2019, Judge William H. Orrick appointed Levi & Korsinsky as lead counsel for the class action lawsuit. The firm has been actively compiling a case against Bloom Energy by, among other things, reviewing the company's public statements and contacting whistleblowers with evidence of fraud.

If you or someone you know can assist Levi & Korsinsky's active case against Bloom Energy, please contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.

To get more information or view copy of Levi & Korsinsky's amended complaint, go to:

https://www.zlk.com/pslra-1/bloom-energy-corporation-loss-form

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 570778

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Has Filed a Complaint to Recover Losses Suffered by Green Dot Corporation Investors and Sets a Lead Plaintiff Deadline of February 17, 2020

NEW YORK, NY / ACCESSWIRE / December 19, 2019 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Green Dot Corporation ("Green Dot" or the "Company") (NYSE:GDOT) between May 9, 2018 and November 7, 2019. You are hereby notified that the class action lawsuit Koffsmon v. Green Dot Corporation et al. (2:19-cv-10701) has been commenced in the United States District Court for the Central District of California. To get more information go to:

https://www.zlk.com/pslra-1/green-dot-corporation-loss-form

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The GDOT lawsuit alleges that Green Dot made false and/or misleading statements and/or failed to disclose that: (1) Green Dot's strategy to attract "high-value" long-term customers was at the expense of "one and done" customers; (2) Green Dot's "one and done" customers represented a significant source of revenues in its legacy segment; (3) consequently, Green Dot's strategy was self-sabotaging; and (4) as a result of the foregoing, Defendants' statements about its business and operations were materially false and misleading at all relevant times.

If you suffered a loss in GDOT you have until February 17, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 570777

Edison issues outlook on ReNeuron Group (RENE)

LONDON, UK / ACCESSWIRE / December 19, 2019 / 2019 has been a transformational year for ReNeuron (LSE:RENE), marked by impressive initial data from the human retinal progenitor cells (hRPC) programme in retinitis pigmentosa (RP) and the initiation of a China partnership with Fosun Pharma (milestone payments of up to £80m and double-digit royalties). In the RP programme, positive data were presented at the AAO annual meeting in San Francisco on eight patients, which further reinforces the data presented earlier in the year. However, long-term durability of effect remains a key question. Further data are expected in H120. In ReNeuron's CTX PISCES III trial in stroke disability patients, the company recently updated its trial design to improve the speed of patient recruitment. Data are expected in mid-2021. We value ReNeuron at £197m.

We value ReNeuron at £197m or 624p per share, versus £198m or 625p per share previously. We have rolled forwards our model, and updated for FX and cash. Additionally, we have increased the probability of success of hRPC in RP to 25% (vs 20% previously) and pushed back CTX launch to 2024 (vs 2023 previously).

Click here to view the full report.

Subscribe to Edison's content to receive reports by email.

All reports published by Edison are free-to-access and available on the website.

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:
Dr Daniel Wilkinson
+44 (0)20 3077 5734
healthcare@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

SOURCE: Edison Investment Research Limited

ReleaseID: 570776

Ludwig Enterprises Inc., Acquires Direct Mortgage Investors Inc.

SPARKS, NV / ACCESSWIRE / December 19, 2019 / Ludwig Enterprises Inc., (OTC PINK:LUDG) Board of Directors is pleased to announce the positive consolidation efforts of Direct Mortgage Investors Inc. (Direct) and the Ludwig team. This is the first of several acquisitions that will allow the company to execute its business plan to roll-up mortgage companies and financial services companies related to the mortgage industry.

Direct Mortgage Investors' management team has worked very hard to transition the daily tasks of the mortgage operation under LUDG. This transition has been deemed successful to date. Direct Mortgage Investors Inc., is now a wholly owned subsidiary of Ludwig Enterprises Inc.

Based in Chicago IL, Direct is a mortgage broker that was formed via multiple brokers and offices coming together in 2017. Direct is licensed in 14 states. The firm has approximately 80 loan officers in multiple offices in Illinois, Michigan and Florida. The principles of Direct, on average, have more than twenty years of experience in the mortgage business.

During the 2018 fiscal year, Direct did $2.4 million in revenue and a little more than $100,000 in profit. For the first nine month of the 2019 year, Direct reported $3.99 million in revenue and $95,000 in net income. The acquisition of Direct is envisioned to be a positive transaction for the shareholders of Ludwig.

Forward-looking statements made in this release are made pursuant to the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. Forward-looking statements made by Ludwig Enterprises, Inc. are not a guarantee of future performance. This news release includes forward-looking statements, including with respect to the future level of business for the parties. These statements are necessarily subject to risk and uncertainty. Actual results could differ materially from those projected in these forward-looking statements as a result of certain risk factors that could cause results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties and events that may be beyond the control of Ludwig Enterprises, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain and successfully complete.

Contact:

Jean Cherubin
CEO
Ludwig Enterprises, Inc.
COB@Ludwigent.com

SOURCE: Ludwig Enterprises Inc.

ReleaseID: 570774